Resveratrol prevents impairment in activation of retinoic acid receptors and MAP kinases in the embryos of a rodent model of diabetic embryopathy

Reproductive Sciences

Volumn 19, Issue 9, 2012, Pages 949-961

  Singh, Chandra K ^a,b   Kumar, Ambrish ^a   Lavoie, Holly A ^a   Dipette, Donald J ^a   Singh, Ugra S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

developmental delays; diabetic pregnancy; MAPKs; resveratrol; retinoic acid receptors

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROFILAMENT PROTEIN; NEUROMODULIN; RESVERATROL; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG EFFECT; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOPATHY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL MODEL; FEMALE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; FETAL DISEASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY IN DIABETICS; RATS; RECEPTORS, RETINOIC ACID; STILBENES;

EID: 84865035723     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112438972     Document Type: Article

References (51)

1. Zabihi S, Loeken MR. Understanding diabetic teratogenesis: where are we now and where are we going?. Birth Defects Res A Clin Mol Teratol. 2010 ; 88 (10). 779-790
2. Oyama K, Sugimura Y, Murase T, et al. Folic acid prevents congenital malformations in the offspring of diabetic mice. Endocr J. 2009 ; 56 (1). 29-37
3. Zhao Z, Reece EA. Experimental mechanisms of diabetic embryopathy and strategies for developing therapeutic interventions. J Soc Gynecol Investig. 2005 ; 12 (8). 549-557
4. Cleves MA, Hobbs CA. Collaborative strategies for unraveling the complexity of birth defects. J Matern Fetal Neonatal Med. 2004 ; 15 (1). 35-38
5. Wroblewska-Seniuk K, Wender-Ozegowska E, Szczapa J. Long-term effects of diabetes during pregnancy on the offspring. Pediatr Diabetes. 2009 ; 10 (7). 432-440
6. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care. 2007 ; 30 (suppl 2). S169 - S174
7. Pavlinkova G, Salbaum JM, Kappen C. Maternal diabetes alters transcriptional programs in the developing embryo. BMC Genomics. 2009 ; 10: 274
8. Fu J, Tay SS, Ling EA, et al. High glucose alters the expression of genes involved in proliferation and cell-fate specification of embryonic neural stem cells. Diabetologia. 2006 ; 49 (5). 1027-1038
9. Dheen ST, Tay SS, Boran J, et al. Recent studies on neural tube defects in embryos of diabetic pregnancy: an overview. Curr Med Chem. 2009 ; 16 (18). 2345-2354
10. Simeoni U, Barker DJ. Offspring of diabetic pregnancy: long-term outcomes. Semin Fetal Neonatal Med. 2009 ; 14 (2). 119-124
11. Van Lieshout RJ, Voruganti LP. Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms. J Psychiatry Neurosci. 2008 ; 33 (5). 395-404
12. Palha JA, Goodman AB. Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia. Brain Res Rev. 2006 ; 51 (1). 61-71
13. Mark M, Ghyselinck NB, Chambon P. Function of retinoic acid receptors during embryonic development. Nucl Recept Signal. 2009 ; 7: e002
14. Wilson L, Gale E, Maden M. The role of retinoic acid in the morphogenesis of the neural tube. J Anat. 2003 ; 203 (4). 357-368
15. Li N, Sun S, Wang D, et al. Suppression of retinoic acid receptors may contribute to embryonic skeleton hypoplasia in maternal rats with chronic vitamin A deficiency. J Nutr Biochem. 2010 ; 21 (8). 710-716
16. Lenhard JM. PPAR gamma/RXR as a molecular target for diabetes. Receptors Channels. 2001 ; 7 (4). 249-258
17. Yan J, Hales BF. p38 and c-Jun N-terminal kinase mitogen-activated protein kinase signaling pathways play distinct roles in the response of organogenesis-stage embryos to a teratogen. J Pharmacol Exp Ther. 2008 ; 326 (3). 764-772
18. Pan J, Kao YL, Joshi S, et al. Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J Neurochem. 2005 ; 93 (3). 571-583
19. Guleria RS, Pan J, Dipette D, et al. Hyperglycemia inhibits retinoic acid-induced activation of Rac1, prevents differentiation of cortical neurons, and causes oxidative stress in a rat model of diabetic pregnancy. Diabetes. 2006 ; 55 (12). 3326-3334
20. Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal. 2009 ; 11 (11). 2851-2897
21. Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011 ; 14 (5). 612-622
22. Banerjee Mustafi S, Chakraborty PK, Raha S.. Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70. PLoS One. 5 (1). e8719
23. Kang MR, Lee SW, Um E, et al. Reciprocal roles of SIRT1 and SKIP in the regulation of RAR activity: implication in the retinoic acid-induced neuronal differentiation of P19 cells. Nucleic Acids Res. 2010 ; 38 (3). 822-831
24. Singh CK, Kumar A, Hitchcock DB, et al. Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. Mol Nutr Food Res. 2011 ; 55 (8). 1186-1196
25. Kumar A, Singh CK, DiPette DD, et al. Ethanol impairs activation of retinoic acid receptors in cerebellar granule cells in a rodent model of fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2010 ; 34 (5). 928-937
26. Dolle P. Developmental expression of retinoic acid receptors (RARs). Nucl Recept Signal. 2009 ; 7: e006
27. Germain P, Chambon P, Eichele G, et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev.. 2006 ; 58 (4). 760-772
28. Corson LB, Yamanaka Y, Lai KM, et al. Spatial and temporal patterns of ERK signaling during mouse embryogenesis. Development. 2003 ; 130 (19). 4527-4537
29. Reece EA, Wu YK, Zhao Z, et al. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. Am J Obstet Gynecol. 2006 ; 194 (2). 580-585
30. Yang P, Zhao Z, Reece EA. Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy. Biochem Biophys Res Commun. 2007 ; 357 (3). 749-754
31. Ates O, Cayli SR, Yucel N, et al. Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J Clin Neurosci. 2007 ; 14 (3). 256-260
32. Palsamy P, Subramanian S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharmacother. 2008 ; 62 (9). 598-605
33. Kutuk O, Poli G, Basaga H. Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling. Toxicol Sci. 2006 ; 90 (1). 120-132
34. Williams LD, Burdock GA, Edwards JA, et al. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem Toxicol. 2009 ; 47 (9). 2170-2182
35. Jang JY, Park D, Shin S, et al. Antiteratogenic effect of resveratrol in mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Eur J Pharmacol. 2008 ; 591 (1-3). 280-283
36. Singh NP, Singh US, Nagarkatti M, et al. Resveratrol (3,5,4′- trihydroxystilbene) protects pregnant mother and fetus from the immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Nutr Food Res. 2011 ; 55 (2). 209-219
37. El-Osta A, Brasacchio D, Yao D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008 ; 205 (10). 2409-2417
38. Salbaum JM, Kappen C. Neural tube defect genes and maternal diabetes during pregnancy. Birth Defects Res A Clin Mol Teratol. 2010 ; 88 (8). 601-611
39. Petersen MB, Pedersen SA, Greisen G, et al. Early growth delay in diabetic pregnancy: relation to psychomotor development at age 4. Br Med J (Clin Res Ed). 1988 ; 296 (6622). 598-600
40. Wilson GN, Howe M, Stover JM. Delayed developmental sequences in rodent diabetic embryopathy. Pediatr Res. 1985 ; 19 (12). 1337-1340
41. Van Assche FA, Holemans K, Aerts L. Long-term consequences for offspring of diabetes during pregnancy. Br Med Bull. 2001 ; 60: 173-182
42. Chan BW, Chan KS, Koide T, et al. Maternal diabetes increases the risk of caudal regression caused by retinoic acid. Diabetes. 2002 ; 51 (9). 2811-2816
43. Chen WH, Morriss-Kay GM, Copp AJ. Genesis and prevention of spinal neural tube defects in the curly tail mutant mouse: involvement of retinoic acid and its nuclear receptors RAR-beta and RAR-gamma. Development. 1995 ; 121 (3). 681-691
44. Dolle P, Fraulob V, Kastner P, et al. Developmental expression of murine retinoid X receptor (RXR) genes. Mech Dev. 1994 ; 45 (2). 91-104
45. Zetterstrom RH, Lindqvist E, Mata de Urquiza A, et al. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci. 1999 ; 11 (2). 407-416
46. Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem. 1996 ; 271 (40). 24313-24316
47. Rana A, Gallo K, Godowski P, et al. The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J Biol Chem.. 1996 ; 271 (32). 19025-19028
48. Sabapathy K, Jochum W, Hochedlinger K, et al. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev. 1999 ; 89 (1-2). 115-124
49. Ornoy A. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol. 2007 ; 24 (1). 31-41
50. Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. Biofactors. 2003 ; 17 (1-4). 287-296
51. Malemud CJ. Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. Curr Opin Pharmacol. 2007 ; 7 (3). 339-343